Facial Harmonization Before Surgery: What Must Be Mapped
“Facial harmonization” is not a diagnosis. Before adding filler, dissolving a product or planning surgery, the clinician must identify whether the concern comes from tissue descent, volume loss, excess volume, edema, skin quality, muscle activity or skeletal proportion.
| Previous treatment | Planning point |
|---|---|
| Hyaluronic-acid filler | May be mapped and selectively dissolved |
| Biostimulator or threads | May alter fibrosis and tissue planes |
| PMMA or silicone | Permanent material; hyaluronidase does not dissolve it |
| Energy treatment | Depth, timing and tissue response should be documented |
Why previous treatments matter
Hyaluronic-acid filler may remain visible or palpable longer than expected and can contribute to excess volume or edema in susceptible areas. Biostimulators and threads may produce fibrosis. PMMA and liquid silicone are permanent materials and cannot be dissolved with hyaluronidase. Energy-based treatments and previous surgery may also alter tissue planes.
A complete history should include the product, treated area, approximate volume, date, number of sessions and any complications. When records are unavailable, the uncertainty becomes part of the surgical risk discussion.
What dermatologic ultrasound can clarify
Dermatologic ultrasound may help locate residual injectable material, distinguish fluid from solid product, identify some areas of fibrosis and guide selected treatment. It does not reveal every material perfectly or replace clinical examination.
Ultrasound is particularly useful when the product is unknown, swelling persists, anatomy looks different from the documented history or surgery would cross a previously treated plane. The findings may support observation, targeted dissolution, further investigation or a change in the surgical plan.
Hyaluronidase has a narrow role
Hyaluronidase acts on hyaluronic acid. It does not dissolve PMMA, silicone, calcium hydroxylapatite, poly-L-lactic acid or transferred fat. Response varies with product, location, distribution and tissue reaction; complete removal cannot be guaranteed.
Dissolution should follow a clinical reason rather than a blanket rule. In some cases, staged treatment and reassessment after swelling settles provide a more reliable baseline. Read the detailed guide to what hyaluronidase can and cannot reverse.
When adding volume is the wrong solution
Filler or microfat can address selected volume deficits, but neither lifts descended tissue in the same way as surgery. Adding volume to a face with heavy lower tissues, malar edema or an already overfilled midface may worsen proportions. Conversely, surgery alone may not correct true skeletal or volume deficiency.
Microfat is used for structural volume in selected planes. Nanofat is more finely processed and does not function as a structural filler. Neither should be described as guaranteed regeneration.
How prior injectables affect facial surgery
For Hybrid Blepharoplasty, old under-eye filler may obscure the lid-cheek junction or contribute to edema. For video-assisted brow or midface surgery, threads and fibrosis may change the plane. For facelift and neck surgery, permanent materials, biostimulators and previous energy treatments may influence dissection and recovery.
The safest plan may be observation, ultrasound, staged dissolution, dermatologic treatment, surgery or no intervention. Technique follows the diagnosis.
Planning from abroad
International patients can begin with records, photographs and video consultation. The final recommendation requires in-person examination. When surgery is indicated, Belvivere coordinates hospital care and follow-up; the concierge team assists with accommodation, transport and scheduling.
This article is educational and does not replace an individualized medical evaluation.
